Authors/Disclosures
|
|
No disclosure on file |
|
Frederick W. Unverzagt, PhD
(Indiana Univ. School of Medicine)
|
No disclosure on file |
|
|
No disclosure on file |
|
George Howard, PhD
(UAB School of Public Hlth)
|
Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. |
|
Virginia J. Howard, PhD
(University of Alabama At Birmingham)
|
The institution of Dr. Howard has received research support from NIH. The institution of an immediate family member of Dr. Howard has received research support from NIH. |
|
|
No disclosure on file |
|
Brendan J. Kelley, MD, FAAN
(University of Texas Southwestern)
|
Dr. Kelley has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Kelley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Labcorp. Dr. Kelley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Esai. |
|
|
No disclosure on file |
|
Claudia Moy, PhD
|
Claudia Moy, PhD has nothing to disclose. |
|
Brett M. Kissela, MD, MS, FAAN
(University of Cincinnati Hospital)
|
The institution of Dr. Kissela has received research support from NIH/NINDS. |
|
|
No disclosure on file |